Intravitreal dexamethasone implant (Ozurdex®) findings over time: ultrasound and ultra-widefield fundus photography.

Background: Ozurdex® (Allergan®, AbbVie Company, North Chicago, Illinois, EUA), is composed of 0.7 mg of dexamethasone, fused in a solid biodegradable PLGA polymer, whose degradation occurs naturally in the vitreous cavity, usually in six months after its application.

Methods: In this study, we included patients aged ≥ 18 years with one or two eyes who had an indication for Ozurdex implants.

Minimally invasive type A aortic dissection repair: aortic valve resuspension with neomedia creation and the Ascyrus Medical Dissection Stent.

Type A aortic dissection is a life-threatening condition that requires immediate surgical intervention. The goal of traditional approaches is to treat the disease promptly, regardless of invasiveness, in order to achieve the quickest surgical outcome. This strategy has been shown to be associated with significant morbidity, extended recovery and postoperative complications.

Biology and medicine on ocular surface restoration: Advancements and limits of limbal stem cell deficiency treatments.

Ocular vision can be hampered by corneal damages, sensibly reducing patients' quality of life and having important social and economic consequences. Ocular surface diseases, which often lead to corneal opacities with visual impairment are the most severe forms of the Limbal Stem Cell Deficiency (LSCD). The present review provides an updated perspective on the available treatments for LSCD, focusing on clinical and biological features, as well as critical points to monitor during clinical translation.

Response of a Blood Clot Adherent to Bone, Oral Mucosa and Hard Dental Tissues to a Uniaxial Tensile Test: An In Vitro Study.

: Periodontal therapy aims to arrest the progression of periodontal diseases and possibly to regenerate the periodontal apparatus. To shift healing from repair to regeneration, the blood clot that fills the periodontal defect and remains in contact with structures such as tooth root, mucosa and bone needs to be stable, which is a reason why the treatment of non-containing periodontal bone defects, in which the clot may undergo displacement, is challenging. The gingival soft tissue, properly sutured, may act as a wall for blood clot stabilization.